Glucagon-like peptide-1 (GLP-1) receptor agonists are increasingly used in the treatment of medlinktype 2 diabetes/medlink and...

learn about suicide and self-harm risks among users of GLP-1 receptor agonists for type 2 diabetes, obesity, and mental health outcomes

learn about suicide and self-harm risks among users of GLP-1 receptor agonists for type 2 diabetes, obesity, and mental health outcomes

WASHINGTON, USA – New research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Madrid, Spain...

WASHINGTON, USA – New research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Madrid, Spain...

A Korean study published recently suggests people with type 2 diabetes who are prescribed a particular class of drug might be at a significantly lower...

A Korean study published recently suggests people with type 2 diabetes who are prescribed a particular class of drug might be at a significantly lower...

Large Korean study suggests sodium-glucose cotransporter-2 inhibitors may lower the risk of dementia

FRIDAY, Aug. 30, 2024 -- Multiple sclerosis (MS) is associated with a lower risk for Alzheimer disease, according to a study published in the...

TUESDAY, Sept. 10, 2024 -- Higher consumption of oats, gluten-containing cereals, and fruits by young children is associated with an increased risk...